Gene Therapies in the Management of Psoriasis

Preview this chapter:

Gene Therapies in the Management of Psoriasis, Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9798898812737/chapter-4-1.gif

Psoriasis is a long-lasting autoimmune dermatological disorder affecting millions of individuals globally, causing substantial physical and psychological distress. While various treatment options, including topical creams, phototherapy, and systemic medications, resulted in relief for several sufferers, a significant portion of those affected by psoriasis remains inadequately treated. In recent years, gene therapy has emerged as a promising frontier in the field of dermatology, offering the potential for more effective and targeted treatments. This chapter reviews the current landscape of gene therapies for the management of psoriasis. It explores the underlying genetic factors contributing to psoriasis susceptibility, emphasizing the role of the immune system and the dysregulation of keratinocyte proliferation. The chapter also explores the various gene therapy approaches being developed to target these specific mechanisms. Recent advancements in gene editing technologies, such as CRISPR-Cas9, have paved the way for precise and targeted modification of genes associated with psoriasis. Researchers are developing strategies to either suppress overactive immune responses or correct genetic mutations that contribute to the pathogenesis of psoriasis. Promising preclinical and clinical results suggest that gene therapies hold the potential to provide long-lasting relief and even a cure for some patients. While gene therapy for psoriasis is still in its experimental stages, early trials have shown encouraging results with minimal side effects. It is essential to acknowledge the challenges and ethical considerations associated with gene therapy, including the need for rigorous safety and efficacy assessments. In conclusion, gene therapies offer a promising avenue for treating psoriasis, with the potential to revolutionize the management of this chronic condition. Ongoing research and clinical trials will determine the safety and effectiveness of these innovative approaches, ultimately providing hope for those suffering from psoriasis and paving the way for personalized, precision medicine in dermatology.